Imugene searching
Top keyword related from Search Engine of imugene
imugene
imugene limited
imugene news
imugene share price
imugene stock
imugene hotcopper
imugene asx
imugene stock forum
imugene shares
imugene proactive investors conference
imugene limited asx share news
imugene share price today
imugene news asx
Top URL related to imugene
-
1. Imugene (ASX: IMU)
imugene.com
Link: https://www.imugene.com/
Description: WEBImugene is a clinical stage immuno-oncology company developing a range of new treatments that seek to activate the immune system of cancer patients to identify and eradicate tumors. ASX: IMU.
-
2. Imugene and Kincell Bio Announce Strategic Manufacturing and …
yahoo.com
Link: https://finance.yahoo.com/news/imugene-kincell-bio-announce-strategic-110000993.html
Description: WEB2 days ago · Imugene is a clinical stage immuno-oncology company developing a range of new and novel immunotherapies that seek to activate the immune system of cancer patients to treat and eradicate tumours.
-
3. Phase 1 CF33-hNIS (VAXINIA) Study Update Shows Positive ... - imugene…
imugene.com
Link: https://www.imugene.com/news/2024/1/17/3pq93y1vv7vipvwu8n6j47cr0dgwag
Description: WEBSydney, Australia, 17 January 2024: Imugene Limited (ASX: IMU), a clinical stage immuno-oncology company, is pleased to provide a clinical trial update of its Phase 1 MAST (Metastatic Advanced Solid Tumours) trial evaluating the safety and efficacy of novel cancer-killing virus CF33-hNIS (VAXINIA).
-
4. Imugene's oncolytic virotherapy VAXINIA and B cell …
yahoo.com
Link: https://finance.yahoo.com/news/imugenes-oncolytic-virotherapy-vaxinia-b-160000531.html
Description: WEBApr 9, 2024 · Imugene Limited. Oncolytic virus CF33-hNIS (VAXINIA) alone or in combination with KEYTRUDA is a safe treatment option for advanced cancer patients. Encouraging VAXINIA efficacy, including a...
-
5. B-Cell Immunotherapies — Imugene (ASX: IMU)
imugene.com
Link: https://www.imugene.com/b-cell-immunotherapies
Description: WEBB-cell immunotherapies link an immunogenic protein with a B-cell epitope and incorporate an adjuvant to produce a B-cell cancer vaccine that induces the body to produce antibodies against the normal self-proteins, such as HER2 or PD-1 …
-
6. Imugene - Wikipedia
wikipedia.org
Link: https://en.wikipedia.org/wiki/Imugene
Description: WEBWebsite. www .imugene .com. Imugene Ltd is a clinical stage immuno-oncology company developing a range of new and novel immunotherapies that seek to activate the immune system of cancer patients to treat and eradicate tumours. Imugene's unique platform technologies seeks to harness the body's immune system against tumours, potentially …
-
7. Bile Tract Cancer expansion study opens following clearance
globenewswire.com
Link: https://www.globenewswire.com/news-release/2024/04/15/2863161/0/en/Bile-Tract-Cancer-expansion-study-opens-following-clearance-of-Imugene-s-MAST-trial-high-dose-cohort.html
Description: WEB3 days ago · Imugene is a clinical stage immuno-oncology company developing a range of new and novel immunotherapies that seek to activate the immune system of cancer patients to treat and eradicate tumours.
-
8. Imugene's oncolytic virotherapy VAXINIA and B cell - GlobeNewswire
globenewswire.com
Link: https://www.globenewswire.com/news-release/2024/04/09/2860250/0/en/Imugene-s-oncolytic-virotherapy-VAXINIA-and-B-cell-immunotherapy-HER-Vaxx-featured-at-the-AACR-Annual-Meeting-2024.html
Description: WEBApr 9, 2024 · Imugene is a clinical stage immuno-oncology company developing a range of new and novel immunotherapies that seek to activate the immune system of cancer patients to treat and eradicate tumours.
-
9. Imugene says Azer-cel could be best-in-class Allogeneic CAR T
yahoo.com
Link: https://finance.yahoo.com/news/imugene-says-azer-cel-could-204000100.html
Description: WEBNov 13, 2023 · Imugene Ltd (ASX:IMU) CEO Leslie Chong speaks with Proactive soon after announcing the company has passed a major milestone for its Azer-cel therapy treatment with the dosing of the first patient...
-
10. City of Hope and Imugene Announce First Patient Dosed in Phase 1 …
businesswire.com
Link: https://www.businesswire.com/news/home/20220517006267/en/City-of-Hope-and-Imugene-Announce-First-Patient-Dosed-in-Phase-1-Trial-to-Test-Cancer-Killing-Oncolytic-Virus-Against-Solid-Tumors
Description: WEBMay 17, 2022 · SYDNEY & LOS ANGELES-- ( BUSINESS WIRE )--Imugene Limited (ASX:IMU), a clinical stage immuno-oncology company, and City of Hope, one of the largest cancer research and treatment organizations in...